Temasek Holdings’s AC Immune ACIU Stock Holding History

Temasek Holdings’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,614,095	Closed	-$19.9M	–	100
2021 Q1	$19.9M	Hold	2,614,095	–	–	0.08%	57
2020 Q4	$13.5M	Hold	2,614,095	–	–	0.06%	58
2020 Q3	$12.8M	Hold	2,614,095	–	–	0.06%	57
2020 Q2	$17.6M	Hold	2,614,095	–	–	0.11%	41
2020 Q1	$18.1M	Hold	2,614,095	–	–	0.13%	41
2019 Q4	$22.3M	Hold	2,614,095	–	–	0.15%	41
2019 Q3	$12.9M	Hold	2,614,095	–	–	0.09%	45
2019 Q2	$14.5M	Hold	2,614,095	–	–	0.1%	43
2019 Q1	$13.2M	Hold	2,614,095	–	–	0.09%	42
2018 Q4	$24.7M	Hold	2,614,095	–	–	0.17%	46
2018 Q3	$20.9M	Buy	2,614,095 +1,276,595	+95%	+$12.8M	0.12%	46
2018 Q2	$12.5M	Hold	1,337,500	–	–	0.07%	52
2018 Q1	$13.8M	Hold	1,337,500	–	–	0.08%	53
2017 Q4	$17.1M	Hold	1,337,500	–	–	0.11%	49
2017 Q3	$14.9M	Hold	1,337,500	–	–	0.09%	48
2017 Q2	$11.8M	Hold	1,337,500	–	–	0.08%	47
2017 Q1	$13.9M	Hold	1,337,500	–	–	0.1%	33
2016 Q4	$17.4M	Hold	1,337,500	–	–	0.14%	32
2016 Q3	$22M	Buy	+1,337,500	New	+$23.1M	0.18%	24

Other funds holding ACIU

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Temasek Holdings's ACIU Position: Q2 2021 in Review

Temasek Holdings sold out of AC Immune (ACIU) in Q2 2021, closing a stake of 2,614,095 shares — an estimated $19.9M sold.

Temasek Holdings first reported a position in ACIU in Q3 2016 and held it in 19 quarters. The position peaked at $24.7M in Q4 2018. 57 funds tracked by Wall St. Rank hold ACIU as of Q2 2021.

Temasek Holdings reported no remaining AC Immune position as of Q2 2021 after selling out during the quarter.
Temasek Holdings sold 2,614,095 AC Immune shares in Q2 2021, an estimated $19.9M.
Temasek Holdings first reported a position in AC Immune in Q3 2016 and held it in 19 quarters.
Temasek Holdings's AC Immune position peaked at $24.7M in Q4 2018.
57 funds tracked by Wall St. Rank held AC Immune as of Q2 2021.

Based on Temasek Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.